Nanyan Rao

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Junjie Li, Ke‐Da Yu, Da Pang et al. · Journal of Clinical Oncology · 2020 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?

Meijun Long, Weijuan Jia, Shunrong Li et al. · Breast Cancer Research and Treatment · 2011 · 52 citations

Medicine, Oncology, Pharmacology +11

Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients

Heran Deng, Lun Chen, Weijuan Jia et al. · Journal of Cancer Research and Clinical Oncology · 2011 · 37 citations · Full text

Medicine, Oncology, Surgery +17

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

Ran Gu, Weijuan Jia, Yunjie Zeng et al. · BMC Cancer · 2012 · 32 citations · Full text

Medicine, Endocrinology, Oncology +14

Clinical Outcomes of Breast-Conserving Surgery in Patients Using a Modified Method for Cavity Margin Assessment

Kai Chen, Yunjie Zeng, Haixia Jia et al. · Annals of Surgical Oncology · 2012 · 31 citations

Medicine, Surgery, Breast Oncology +9